KYPROLIS
Active substance: carfilzomib
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · CARFILZOMIB 60 mg/30mL
United StatesActive
Marketing holder: Onyx Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- CARFILZOMIB · 60 mg/30mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-309a-78a9-98dd-5248d3a20734,01a12099-f44f-7d80-881b-58c67ce0ca69,01a1209c-2b0e-7602-b514-8163c23dfb89;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 76075-101
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 76075-101 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 76075-101 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 76075-101 · Verified 2026-10-09 · open in source